On April 21, director Zhengyi accepted an interview with Henan satellite TV news center on the case of "Xinhua trademark" represented by our office.

Shandong Xinhua Pharmaceutical Co., Ltd. is the exclusive user of the "Xinhua" trademark. The name of a pharmaceutical company in Henan is also "Xinhua", and a logo with the words "Xinhua Pharmaceutical" is used in its website. After hearing the case, the Zhengzhou intermediate people's court held that Shandong Xinhua and "Xinhua" trademarks are well-known in the industry. When a pharmaceutical company in Henan applied for enterprise registration, it should bear the relevant duty of care, take the initiative to avoid, order a pharmaceutical company in Henan to stop infringement, and compensate Shandong Xinhua company for its economic loss of 200000 yuan.

A pharmaceutical company in Henan refused to accept the appeal, and shixiaohong, vice president of the provincial high court, personally acted as the presiding judge to try the case. Finally, a pharmaceutical company in Henan agreed to stop infringing on the trademark rights of Shandong Xinhua, change its name within a time limit, and compensate Shandong Xinhua for its losses.

The conclusion of this case is of great significance. The pharmaceutical industry is an important part of the social health service industry. The conclusion of this case has established the market competition rules of the pharmaceutical industry, avoiding people's wrong understanding and affecting their right to choose drugs when seeking medical treatment. The trial of this case has played a good exemplary role in regulating the market competition order of the pharmaceutical industry.

The case of "Xinhua trademark" represented by our office shows the high-level professional quality and strength in the field of intellectual property business.